Taisho Pharmaceutical Holdings

Taisho Pharmaceutical Holdings is a pharmaceutical company engaged in the manufacturing of specialty and generic drugs. The company operates through two main segments: Self-Medication and Prescription Pharmaceuticals, with the majority of its revenue coming from the Self-Medication segment. Taisho Pharmaceutical primarily generates its sales from external customers in Japan. The company is also open to pursuing mergers and acquisitions as a strategy to enhance its research, development, manufacturing, and marketing capabilities, thereby supporting its operational growth.

Akira Uehara

CEO and Board Member

6 past transactions

Biolinq

Series B in 2021
Biolinq Inc. is a San Diego-based company that specializes in developing skin-applied electronic sensors designed to analyze body fluids for health monitoring. Founded in 2012 and originally known as Electrozyme LLC, Biolinq aims to enhance the experience of individuals with diabetes by providing a more affordable and pain-free alternative to conventional continuous glucose monitoring (CGM) systems. The company's platform features minimally invasive electrochemical biosensors capable of measuring multiple analytes, including glucose, ketones, and lactate. This innovative technology not only facilitates easier blood glucose monitoring but also delivers actionable insights into metabolic health, significantly improving the quality of life for patients managing diabetes.

Moodify

Series A in 2021
Moodify Ltd is a Tel Aviv-based company founded in 2017 that specializes in artificial intelligence and machine learning solutions aimed at enhancing emotional well-being. The company has developed an innovative platform that employs artificial empathy to deliver cognitive behavioral therapy. By continuously gathering biometric data, Moodify's technology can respond in real-time to users' emotional states, thereby improving attention and fostering positive emotions. One of its key offerings, the Empathic Car system, enables vehicles to intuitively sense and address the emotional needs of drivers, utilizing scent technology to emit safe and non-intrusive signals that influence mood.

aiwell

Corporate Round in 2020
aiwell Inc. is a Tokyo-based company focused on the research and development of AI proteomics, a technology that analyzes protein changes in living organisms. The company has developed a platform that digitizes proteins from humans and livestock, facilitating sample processing and enabling the analysis of small-volume samples and image data comparison. aiwell offers a micro blood sampling kit called aiwell care, which allows users to conduct blood tests easily. Additionally, the company provides AI-based support for diagnosis, drug discovery, and remote medical care. aiwell engages in collaborative research with the Tokyo Institute of Technology and utilizes two-dimensional electrophoresis technology to enhance sample sensitivity and throughput, assisting medical practitioners in making accurate assessments, particularly in cases of sepsis. Founded in 2018, aiwell Inc. was previously known as CF Partners Co., Ltd.

Nanotis

Series A in 2020
Nanotis Corporation, founded in 2016 and based in Tokyo, Japan, specializes in the development of instant diagnostic devices, particularly for infectious diseases such as influenza. The company manufactures microchip devices that allow users to achieve rapid and accurate diagnoses, which are essential for medical professionals in practical healthcare settings. By providing timely information, Nanotis aims to enhance the efficiency of healthcare delivery and assist individuals facing health challenges.

Quantum Operation

Corporate Round in 2020
Quantum Operation, Inc. engages in development of smart watches for blood sugar level management and to prevent heat stroke. The company also develops speech recognition systems, digital signage solutions, and AI surveillance cameras. In addition, it offers IoT consulting and YouTuber movie production services. The company was founded in 2017 and is based in Tokyo, Japan.

UPSA

Acquisition in 2018
UPSA SAS specialists in the fight against pain and self-medication. UPSA SAS offers pharmaceuticals, food supplements, and medical devices for patients ranging from infants to seniors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.